glp-1 receptor activation Understanding agonists and their impact on drug discovery PDB-101: Molecule of the Month:

Lilly announced the topline results from its phase 3b "TOGETHER PsA" trial, showing that the combination use of ixekizumab (Taltz) and tirzepatide (Zepbound) was superior to IXE alone, yielding both significant weight loss and ACR50 disease control in adults with active psoriatic arthritis (PsA).

Learn how to adjust your diet to get the most out of your GLP-1 and minimize side effects.

Unravel the intricacies of drug discounts and rebates within the pharmaceutical landscape, focusing on the pivotal role played by Pharmacy Benefit Managers (PBMs)

With nearly 38% of Tennessee adults living ...

Demand for these three GLP-1 brands, across their various brands and formulations, has led to unprecedented levels of media attention and unsolicited celebrity endorsements that has resulted in unexpected and intermittent supply shortages

Long, unpredictable shifts meant going eight hours without a proper meal, then coming home utterly exhausted and eating whatever was in front of me